Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for total intravenous intubation general anesthesia in urologic surgery
ChiCTR2100050923Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Efficacy of anesthesia regimen. Started Jan 2022; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100050923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050923.